Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-21 4:01 pm Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | Hafner Ronald | 310,958 8.100% | 310,958 (New Position) | View |
| 2024-11-14 7:27 pm Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | Lind Global Fund II LP | 103,530 8.100% | 103,530 (New Position) | View |
| 2024-11-14 3:33 pm Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | ARMISTICE CAPITAL LLC | 129,475 9.990% | 129,475 (New Position) | View |
| 2024-11-04 7:39 pm Sale | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | YA II PN Ltd. | 0 0.000% | -3,959,128 (Position Closed) | View |
| 2024-11-04 6:20 pm Sale | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | Grisard Felix | 107,366 2.800% | -3,135,523 (-96.69%) | View |
| 2024-10-15 1:24 pm Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | ALPHA CAPITAL ANSTALT | 246,996 9.990% | 246,996 (New Position) | View |
| 2024-03-27 7:37 pm Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | Lind Global Fund II LP | 4,300,000 9.900% | 4,300,000 (New Position) | View |
| 2024-02-12 4:37 pm Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | YA II PN Ltd. | 3,959,128 9.990% | 912,117 (+29.93%) | View |
| 2023-02-24 07:55 am Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | Grisard Felix | 3,242,889 9.990% | 3,242,889 (New Position) | View |
| 2023-02-14 4:32 pm Sale | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | Magnetic Rock Investment AG | 2,845,000 8.770% | -410,000 (-12.60%) | View |
| 2023-02-13 7:32 pm Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | Konofal Eric | 1,025,000 3.200% | 5,000 (+0.49%) | View |
| 2023-02-13 4:02 pm Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | Zwyer Alexander | 1,254,000 3.900% | 54,000 (+4.50%) | View |
| 2023-01-03 3:58 pm Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | YA II PN Ltd. | 3,047,011 9.990% | 1,441,182 (+89.75%) | View |
| 2022-12-16 4:45 pm Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | BIOTECHNOLOGY VALUE FUND L P | 6,859,146 19.990% | 6,859,146 (New Position) | View |
| 2022-02-24 06:06 am Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | Konofal Eric | 1,020,000 6.300% | 1,020,000 (New Position) | View |
| 2022-02-18 5:30 pm Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | Magnetic Rock Investment AG | 3,255,000 20.000% | 3,255,000 (New Position) | View |
| 2022-02-14 08:03 am Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | Zwyer Alexander | 1,200,000 7.400% | 1,200,000 (New Position) | View |
| 2022-01-11 4:52 pm Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | YA II PN Ltd. | 1,605,829 9.990% | 266,394 (+19.89%) | View |
| 2021-10-07 6:24 pm Purchase | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | YA II PN Ltd. | 1,339,435 9.990% | 1,339,435 (New Position) | View |
| 2021-03-17 4:10 pm Sale | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | HIRSCHMAN ORIN | 577,185 4.900% | -342,815 (-37.26%) | View |